Riskpilot← Back to searchSign inGet full accessIDT BIOLOGIKA ApS
APSDissolvedCVR 34697647Herredsvejen 2Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 20124 employees
Revenue 2019
DKK 2,9M
-28% vs 2018
EBITDA margin
-0.1%
-104% vs 2018
Equity ratio
100.0%
Financial strength
Net profit 2019
DKK -24K
-143% vs 2018
| Revenue | DKK 2,9M | -28% |
| EBITDA | DKK -4K | -104% |
| Net profit | DKK -24K | -143% |
| Total assets | DKK 673K | -56% |
| Equity | DKK 673K | -3% |
| Employees | 4 | — |
Legal name
IDT BIOLOGIKA ApS
CVR number
34697647
Legal form
Anpartsselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
4. september 2012
Share capital
DKK 80.000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et direktionsmedlem eller af den samlede direktion i forening.
Address
Herredsvejen 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Revenue | 4.196 | 5.573 | 5.016 | 4.077 | 2.946 |
| Staff expenses | -1.642 | -2.828 | -2.526 | -2.430 | -1.366 |
| EBITDA | 165 | 134 | 356 | 94 | -4 |
| Depreciation & amort. | -0 | -4 | -5 | -5 | -3 |
| EBIT | 165 | 130 | 350 | 89 | -7 |
| Net financials | -2 | -11 | -10 | -15 | -8 |
| Profit before tax | 162 | 120 | 340 | 74 | -15 |
| Tax | 49 | 37 | 90 | 19 | 9 |
| Net profit | 114 | 82 | 250 | 55 | -24 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 |
|---|---|---|---|---|---|
| Total assets | 1.137 | 1.274 | 1.837 | 1.537 | 673 |
| Equity | 309 | 391 | 642 | 697 | 673 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 828 | 882 | 1.195 | 839 | 0 |
| Total debt | 828 | 882 | 1.195 | 839 | 0 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20152019
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20152019
Return on equity
-3.5%
This company
18.4%
Market median
-119% vs market
20152019
Net profit margin
-0.8%
This company
8.1%
Market median
-110% vs market
20152019
Asset turnover
4.38×
This company
1.12×
Market median
+291% vs market
20152019
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20152019
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since |
|---|---|---|
| Former (5) | ||
CS Management | Management | 2012 – 2012 |
GB Management | Management | 2012 – 2016 |
AJ | Management | 2016 – 2020 |
AJ | Management | 2016 – 2016 |
CW Management | Management | 2018 – 2020 |
| Name | Role | Member since |
|---|---|---|
| Former (6) | ||
| Chairman | 2016 – 2018 | |
| Board of Directors | 2012 – 2016 | |
| Board of Directors | 2016 – 2018 | |
| Board of Directors | 2012 – 2016 | |
| Chairman | 2018 – 2018 | |
| Chairman | 2012 – 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IDT BIOLOGIKA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Caroline Sundorph Pontoppidan | Management | 0 companies |
| Gert Barysch | Management | 0 companies |
| Andreas Joseph Ludwig Friedrich Kastenbauer | Management | 0 companies |
| Andreas Joseph Ludwig Friedrich Kastenbauer | Management | 0 companies |
| Christian Wirth | Management | 0 companies |
| Dr. Ralf Friedrich Pfirmann | Chairman | 0 companies |
| Niels Gürke | Board of Directors | 0 companies |
| Peter Charles Linzmeyer | Board of Directors | 0 companies |
| Peter Charles Linzmeyer | Board of Directors | 0 companies |
| Niels Gürke | Chairman | 0 companies |
| Ralf Friedrich Pfirmann | Chairman | 0 companies |